VANGUARD GROUP INC 13D and 13G filings for Ocugen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-31 11:03 am Sale | 2025-09-30 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 15,223,585 4.870% | -1,725,434 (-10.18%) | Filing |
| 2024-11-12 4:59 pm Unchanged | 2024-09-30 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 16,949,019 5.880% | 0 (Unchanged) | Filing |
| 2024-11-04 1:43 pm Purchase | 2024-09-30 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 16,949,019 5.880% | 4,909,101 (+40.77%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 12,039,918 4.690% | 180,775 (+1.52%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 11,859,143 5.420% | 1,253,649 (+11.82%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 10,605,494 5.320% | 1,530,501 (+16.87%) | Filing |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | Ocugen, Inc. OCGN | VANGUARD GROUP INC | 9,074,993 5.600% | 9,074,993 (New Position) | Filing |